<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-154903" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Toluene Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Holmes</surname>
            <given-names>Matthew D.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murray</surname>
            <given-names>Brian P.</given-names>
          </name>
          <aff>Wright State University Boonshoft School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Holmes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brian Murray declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-154903.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Toluene is a simple benzene derivative also known as methylbenzene, phenylmethane,&#x000a0;or toluol. Chronic low-level occupational or industrial exposure to toluene can cause toxicity.&#x000a0;As a volatile solvent, misuse or abuse is common, resulting in an acute toxidrome. Toluene is an aromatic hydrocarbon with narcotic and neurotoxic effects and, like all inhalants, has the potential to&#x000a0;induce addiction pathology.<xref ref-type="bibr" rid="article-154903.r1">[1]</xref><xref ref-type="bibr" rid="article-154903.r2">[2]</xref>&#x000a0;The mechanism of action of toluene is not clearly understood, but toluene&#x000a0;appears to affect a wide variety of voltage-gated and ligand-gated ion channels.<xref ref-type="bibr" rid="article-154903.r2">[2]</xref></p>
        <p>Recent literature suggests that toluene profoundly modulates dopaminergic neuronal firing from the ventral tegmental area into the limbic and cortical structures, altering signaling-reward pathways.<xref ref-type="bibr" rid="article-154903.r3">[3]</xref><xref ref-type="bibr" rid="article-154903.r4">[4]</xref><xref ref-type="bibr" rid="article-154903.r5">[5]</xref><xref ref-type="bibr" rid="article-154903.r6">[6]</xref><xref ref-type="bibr" rid="article-154903.r7">[7]</xref><xref ref-type="bibr" rid="article-154903.r8">[8]</xref></p>
        <p>Most commonly, studies highlight the prevalence and toxicity associated with acute exposures. Toluene is perceived as safe amongst individuals who misuse solvents and is readily available in multiple formulations meant for household purposes. Therefore, acute toxicity is a common occurrence. While data regarding the precise frequency of toluene toxicity is limited, a single-center emergency department reported 20 acute toxicities within&#x000a0;2 years.<xref ref-type="bibr" rid="article-154903.r9">[9]</xref> However, this may be an underestimation as toluene is ubiquitous in our society, and many individuals experiencing toxicity may not seek care or want to seek care.</p>
      </sec>
      <sec id="article-154903.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Toluene (C<sub>7</sub>H<sub>8</sub>) is a colorless aromatic hydrocarbon with a wide range of industrial utility. Toluene is used to manufacture plastics, nylon, and polyurethane and as a solvent in paints, inks, adhesives, fragrances, coatings, and cleaning agents. In veterinary medicine, toluene is used to remove ascarids and tapeworms. The United States military uses toluene to manufacture 2,4,6-Trinitrotoluene (TNT), a dangerously explosive nitroaromatic. Toluene is also an important petrochemical used to improve the octane rating of gasoline. [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/Toluene">National Center for Biotechnology Information. PubChem Compound Summary for CID 1140, Toluene.</ext-link>]</p>
        <p>Approximately 30 billion pounds or 13.6&#x000a0;million metric tons of toluene is produced yearly. Exposure limits have been established for manufacturing plants, construction sites, nail salons, printing establishments, maritime employment, and automobile repair facilities.</p>
        <p>The Occupational Safety and Health Administration (OSHA) uses a reference concentration of 5 mg/m<sup>3</sup>. At this concentration, the acute minimal risk level is 2 ppm (exposure from 1 to 14 days), while the chronic minimal risk level is 1 ppm (greater than 365 days). The permissible exposure limit is 200 ppm for 8 hours, with an acceptable ceiling concentration of 300 ppm and an acceptable peak beyond the ceiling concentration of 500 ppm over 10 minutes. The National Institute for Occupational Safety and Health (NIOSH) recommends a more stringent standard of 100 ppm for 8 hours with an acceptable peak of 150 ppm over 15 minutes. (NIOSH. Toluene standards) Both organizations recommend the minimum use of personal protective equipment for chemical cartridge respirators with organic vapor cartridges, with additional recommendations based on time and concentration of exposure.</p>
        <p>There is limited data on dermal exposure limits. However, multiple studies have reported defatting dermatitis, pruritus, and epidermal thickening with repeated exposures.<xref ref-type="bibr" rid="article-154903.r10">[10]</xref><xref ref-type="bibr" rid="article-154903.r11">[11]</xref>&#x000a0;An estimated exposure concentration that resulted in dermatitis and pruritus was reported in female shoe workers as 65 ppm (15 ppm to 100 ppm) in winter to 100 ppm (10 ppm to 200 ppm) in summer over 40 months.<xref ref-type="bibr" rid="article-154903.r10">[10]</xref><xref ref-type="bibr" rid="article-154903.r11">[11]</xref>&#x000a0;</p>
        <p>Outside of occupational exposure, toluene can be found in the atmosphere, water sources, and soil. Domestic manufacturing and processing facilities release an estimated 22 million pounds (10,000 metric tons) of toluene into the atmosphere annually. Newly constructed buildings and areas of high gasoline emissions are noted&#x000a0;in areas of heightened concentrations, eg, a new apartment has levels as high as 66.06 &#x003bc;g/m3. In comparison, the outdoor levels were 11.05 &#x003bc;g/m<sup>3</sup>. An estimated 54,000 pounds (245 metric tons) of toluene is released from industrial discharge and spill incidents into local water sources. Water sources neighboring hydraulic fracturing operations in Colorado had a mean sample concentration of 750 &#x003bc;g/L with a 95th percentile concentration of 1,900 &#x003bc;g/L. Approximately 1.3 million pounds (590 metric tons) of toluene are estimated to be released into the soil.&#x000a0;</p>
        <p>There are additional groups that have&#x000a0;provided recommendations on occupational exposure limits. The Lower Olefins and Aromatics (LOA) REACH Consortium recognizes 100 ppm over 15 minutes or 20 ppm over&#x000a0;8 hours before side effects occur.<xref ref-type="bibr" rid="article-154903.r12">[12]</xref> Excessive amounts greater than 500 ppm are&#x000a0;associated with a range of clinical presentations, from acute euphoric effects to organ failure and sudden death.<xref ref-type="bibr" rid="article-154903.r13">[13]</xref><xref ref-type="bibr" rid="article-154903.r14">[14]</xref><xref ref-type="bibr" rid="article-154903.r15">[15]</xref><xref ref-type="bibr" rid="article-154903.r16">[16]</xref></p>
      </sec>
      <sec id="article-154903.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Toluene is the most commonly misused volatile solvent. The prevalence of toluene misuse and acute toxicity peaks at 12 to 14 years of age and significantly declines after age 18, perhaps reflecting a shift to other substances.<xref ref-type="bibr" rid="article-154903.r2">[2]</xref><xref ref-type="bibr" rid="article-154903.r17">[17]</xref><xref ref-type="bibr" rid="article-154903.r18">[18]</xref>&#x000a0;Reports of toluene misuse are significantly higher in boys and young men than in girls and young women.<xref ref-type="bibr" rid="article-154903.r19">[19]</xref> The reported prevalence rate of toluene misuse amongst American 8th to 12th graders has been steady for the past 20 years at 10%;&#x000a0;only marijuana has a higher reported usage rate in this age group.<xref ref-type="bibr" rid="article-154903.r17">[17]</xref> Worldwide, the highest prevalence rates of toluene misuse are found in Brazil (16.5%) and Australia (10.3%),&#x000a0;while Canada (3% to 5%) and Japan (1.2%) are among the countries with the lowest prevalence.<xref ref-type="bibr" rid="article-154903.r17">[17]</xref><xref ref-type="bibr" rid="article-154903.r18">[18]</xref><xref ref-type="bibr" rid="article-154903.r19">[19]</xref> Communities that are disproportionately affected by toluene toxicity include indigenous groups located in America, Australia, and Canada, with rates ranging from 50% to 60%.<xref ref-type="bibr" rid="article-154903.r18">[18]</xref></p>
        <p>Toluene is ubiquitous in general, maritime, construction, and petrochemical industries. The prevalence and exposure rates among industrial workers have yet to be established, as toluene is typically found. OSHA and NIOSH have identified groups at increased risk of toluene exposure, including workers near underground gasoline storage tanks, nail salon technicians, construction workers who use adhesives, solvents, and paints, and workers involved in gasoline production. (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.osha.gov/toluene">OSHA. Toluene Standards.</ext-link>)(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/niosh/topics/toluene/">NIOSH. Toluene standards.</ext-link>)</p>
      </sec>
      <sec id="article-154903.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Toluene exposure may occur via inhalational, transdermal, or absorptive routes. Inhalational exposure, whether occupational, accidental, or intentional, is the most common. Acute toluene toxicity can result from ingestion, leading to gastrointestinal absorption.<xref ref-type="bibr" rid="article-154903.r9">[9]</xref></p>
        <p>Toluene is rapidly absorbed from the lungs and gastrointestinal tract but absorbed at low concentrations following transdermal exposure.&#x000a0;Toluene is lipophilic and readily crosses cell membranes, blood-brain, and placental barriers.<xref ref-type="bibr" rid="article-154903.r20">[20]</xref> Following absorption, toluene is widely distributed in well-vascularized tissues, including the central and peripheral nervous systems, liver, kidneys, and bone marrow. Peak absorption following inhalation occurs within 15 to 30 minutes.<xref ref-type="bibr" rid="article-154903.r20">[20]</xref>&#x000a0;In a study of 6 healthy subjects exposed to toluene vapor for 4 hours, the concentrations of toluene in the brain and the blood were&#x000a0;exponentially correlated&#x000a0;to toluene in the air.<xref ref-type="bibr" rid="article-154903.r21">[21]</xref>&#x000a0;</p>
        <p>The onset of an acute toxidrome may occur within seconds, and the concentration of toluene and length of exposure dictates the duration of adverse effects. The half-life of toluene is estimated to be 3 minutes in highly vascularized organs, 40 minutes in soft tissue, and more than 12 hours in adipose tissue.<xref ref-type="bibr" rid="article-154903.r20">[20]</xref></p>
        <p>The metabolism of toluene predominately occurs via&#x000a0;2 pathways. Cytochrome P450 isozymes, predominately CYP2E1, catalyze methyl hydroxylation to form benzyl alcohol. Alcohol dehydrogenase and aldehyde dehydrogenase oxidize benzyl alcohol to yield benzoic acid. Conjugation with glycine forms hippuric acid, the major metabolite (95%), or glucuronic acid, forming benzyl glucuronide. The second major pathway begins with ring hydroxylation of toluene with similar P450 isozymes to yield epoxide intermediates, precursors to various aromatic configurations of cresol. Conjugation with sulfate or glucuronic acid yields a trace amount of metabolites.<xref ref-type="bibr" rid="article-154903.r2">[2]</xref><xref ref-type="bibr" rid="article-154903.r20">[20]</xref><xref ref-type="bibr" rid="article-154903.r22">[22]</xref></p>
        <p>Most toluene is eliminated after 20 hours of exposure through urination as hippuric acid (31% to 80%) and other metabolites (3% to 4%), exhalation as intact toluene (7% to 14%), and bile (2%).<xref ref-type="bibr" rid="article-154903.r20">[20]</xref></p>
        <p>Toluene toxicity leads to a range of acute and chronic effects that are attributed to its major metabolite, hippuric acid. The hallmark of toluene toxicity is type 1 renal tubular acidosis. Toluene is metabolized to hippuric acid by cytochrome p-450 enzymes, which deprotonates in plasma to hippurate, then ionically binds with ammonium, sodium, or potassium cations and is excreted in the urine.<xref ref-type="bibr" rid="article-154903.r9">[9]</xref>&#x000a0; Additionally, toxicity may be associated with hypokalemia, resulting in weakness, spasticity, cardiac arrhythmias, and other complications such as rhabdomyolysis.<xref ref-type="bibr" rid="article-154903.r9">[9]</xref></p>
        <p>Neurologic features of toluene toxicity include early euphoria followed by emotional lability, dizziness, dysarthria, ataxia, and visual or auditory hallucinations. Known neuronal targets of toluene include N-methyl-D-aspartate (NMDA), gamma-aminobutyric acid (GABA), and serotonin (5HT3).&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>NMDA: non-competitively inhibits NMDA receptors, leading to an influx of chlorine through the cellular membrane, neuronal hyperpolarization, inhibition of nerve impulse propagation, and central nervous system depression.<xref ref-type="bibr" rid="article-154903.r23">[23]</xref><xref ref-type="bibr" rid="article-154903.r20">[20]</xref><xref ref-type="bibr" rid="article-154903.r24">[24]</xref><xref ref-type="bibr" rid="article-154903.r25">[25]</xref><xref ref-type="bibr" rid="article-154903.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>GABA: enhances GABA receptor function, increasing pyramidal neurons' inhibitory tone. This is especially true within the hippocampus, and chronic exposure leads to decreased cognition and learning disabilities.<xref ref-type="bibr" rid="article-154903.r25">[25]</xref><xref ref-type="bibr" rid="article-154903.r3">[3]</xref><xref ref-type="bibr" rid="article-154903.r26">[26]</xref><xref ref-type="bibr" rid="article-154903.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>5HT3: reversible, concentration-dependent potentiation of serotonin-3A is seen with toluene exposure, which is further attributed to signaling alterations consistent with addiction.<xref ref-type="bibr" rid="article-154903.r27">[27]</xref><xref ref-type="bibr" rid="article-154903.r25">[25]</xref><xref ref-type="bibr" rid="article-154903.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>nAchR: inhibits<xref ref-type="bibr" rid="article-154903.r25">[25]</xref><xref ref-type="bibr" rid="article-154903.r23">[23]</xref></p>
          </list-item>
        </list>
        <p>Chronic exposure, including occupational or repeat misuse, may cause permanent effects such as cognitive impairment and behavior irregularities from changes in neuronal spasticity and signaling pathways listed above.<xref ref-type="bibr" rid="article-154903.r3">[3]</xref> Defatting has been reported from multiple sources, which can lead to dermatitis on the distal upper extremities, mouth, and nose.<xref ref-type="bibr" rid="article-154903.r28">[28]</xref><xref ref-type="bibr" rid="article-154903.r29">[29]</xref>&#x000a0;This same defatting has been seen in neurologic complications attributed to toluene, termed &#x0201c;toluene leukoencephalopathy,&#x0201d; in which autopsy reports demonstrated atrophy and mottling of white matter as though the lipid-based myelin was dissolved away.<xref ref-type="bibr" rid="article-154903.r30">[30]</xref>&#x000a0;Similar to the features found in an individual with fetal alcohol syndrome, fetal solvent syndrome has been described in children born to women with chronic toluene misuse.<xref ref-type="bibr" rid="article-154903.r15">[15]</xref><xref ref-type="bibr" rid="article-154903.r31">[31]</xref></p>
      </sec>
      <sec id="article-154903.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histological features of toluene toxicity are primarily studied in mice and rat lungs, brains, and kidneys. Toluene-treated mouse lung demonstrated irregular cellular architecture with compaction of the interalveolar septum, alveolar septa thickening, deposition of fibrous node-like structures, and hyperplasia.<xref ref-type="bibr" rid="article-154903.r32">[32]</xref> Mice exposed to toluene&#x000a0;had increased expression of glial fibrillary acidic protein and astrogliosis in the hippocampus, cortex, and cerebellum.<xref ref-type="bibr" rid="article-154903.r33">[33]</xref> Rat kidneys were noted to have massive tubular degeneration, glomerular disorganization with shrinkage, congestion, and tubular cell vacuolization.<xref ref-type="bibr" rid="article-154903.r34">[34]</xref></p>
      </sec>
      <sec id="article-154903.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>During history intake, special consideration should be given to potential exposure sources (eg, occupation, travel, or home renovations), and if explicitly stated by the patient, the characteristics of the exposure (eg, product inhaled, the evolution of symptoms, chronicity, and concomitant substance misuse).&#x000a0;</p>
        <p>A physical examination should involve all systems as no set of findings exists that are specific to toluene toxicity nor dichotomize acute versus chronic exposure.<xref ref-type="bibr" rid="article-154903.r2">[2]</xref> There&#x000a0;is a progression of stages after acute exposure to toluene described by multiple studies: euphoria followed by excitability, disinhibition, and impulsive behaviors.<xref ref-type="bibr" rid="article-154903.r18">[18]</xref><xref ref-type="bibr" rid="article-154903.r35">[35]</xref><xref ref-type="bibr" rid="article-154903.r36">[36]</xref><xref ref-type="bibr" rid="article-154903.r37">[37]</xref>&#x000a0;</p>
        <p>Major clinical presentations by the system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neurologic: Headache, slurred speech, diplopia, mood lability, loss of motor control, illusions, hallucinations, dizziness, and nausea. Progression of toxicity can lead to obtundation characterized by seizures, coma, and death. Chronic users can have cognitive impairment, encephalopathy, and changed social behaviors.<xref ref-type="bibr" rid="article-154903.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Cardiac: Arrhythmias that can be initially identified by palpation or auscultation via alteration in the strength or rate of cardiac activity.<xref ref-type="bibr" rid="article-154903.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Pulmonary: Persistent cough and respiratory distress with breath sounds that can either be clear or have adventitious sounds such as rhonchi or wheezing.<xref ref-type="bibr" rid="article-154903.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Renal: Pyuria, dysuria, and hematuria.<xref ref-type="bibr" rid="article-154903.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Integumentary: Areas notable for defatting dermatitis, irritation, and pruritus, especially on the distal upper extremities, mouth, and nose.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-154903.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial evaluation should address airway compromise, respiratory distress, and circulatory collapse. Vital signs, including temperature, cardiac evaluation with an electrocardiogram, pulmonary evaluation with chest radiography and ultrasound, and serology or urine studies revealing end-organ dysfunction or electrolyte abnormalities&#x000a0;must assess&#x000a0;a broad differential diagnosis. Focal neurological deficits may warrant imaging studies.</p>
        <p>Hydrocarbon toxicity is difficult to identify, which is more complicated as no laboratory study is available to confirm exposure.<xref ref-type="bibr" rid="article-154903.r36">[36]</xref> While gas chromatography can identify volatile substances, this is not feasible for emergent assessment. Hippuric acid levels in urine greater than 3&#x000a0;g per gram of creatinine are 98.1% sensitive and 100% specific for toluene toxicity, and urine hippuric acid is the preferred way to monitor for exposure in high-risk occupations.<xref ref-type="bibr" rid="article-154903.r41">[41]</xref></p>
        <p>Additional findings that may be present in the setting of toluene toxicity include hypokalemia (with associated electrocardiogram changes), low bicarbonate, elevated creatinine phosphokinase, and hematuria.<xref ref-type="bibr" rid="article-154903.r42">[42]</xref><xref ref-type="bibr" rid="article-154903.r43">[43]</xref><xref ref-type="bibr" rid="article-154903.r44">[44]</xref></p>
      </sec>
      <sec id="article-154903.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of toluene toxicity focuses on airway management, correcting metabolic acidosis and electrolyte abnormalities, and counseling the patient on the dangers of toluene exposure. Patients should be hospitalized for laboratory monitoring until such derangements are addressed.&#x000a0;</p>
        <p>Specific management of toluene toxicity is limited to small clinical trials and case studies. Of note, there have been data to suggest the administration of acetaminophen and aspirin as they may inhibit toluene metabolism (CYP2E1 as the site of competitive metabolic interaction), limiting the acute production of hippuric acid.<xref ref-type="bibr" rid="article-154903.r21">[21]</xref> In a study with 40 subjects, psychosis or behavioral changes were reduced by treatment with carbamazepine and haloperidol by 50%.<xref ref-type="bibr" rid="article-154903.r38">[38]</xref> Aggressive fluid management is helpful as toluene metabolites are water soluble and renally excreted.<xref ref-type="bibr" rid="article-154903.r45">[45]</xref> Patients presenting in extremis due to toluene toxicity have benefited from extracorporeal membrane oxygenation.<xref ref-type="bibr" rid="article-154903.r46">[46]</xref></p>
        <p>Neither gastric lavage nor activated charcoal administration is recommended due to aspiration risk and limited gastrointestinal absorption.<xref ref-type="bibr" rid="article-154903.r47">[47]</xref><xref ref-type="bibr" rid="article-154903.r48">[48]</xref>&#x000a0;All cases should be reported to the local poison control center for further guidance.</p>
      </sec>
      <sec id="article-154903.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for toluene toxicity is broad, as its presenting symptoms&#x000a0;are nonspecific. The main features of toluene toxicity include altered mental status, pneumonitis, and metabolic acidosis. While this list is not exhaustive, an accurate history is critical.</p>
        <list list-type="order">
          <list-item>
            <p>Substance misuse (barbiturates, benzodiazepines, opioids)</p>
          </list-item>
          <list-item>
            <p>Medication overdose (lithium, diuretics)</p>
          </list-item>
          <list-item>
            <p>Carbon monoxide exposure</p>
          </list-item>
          <list-item>
            <p>Benzene inhalation</p>
          </list-item>
          <list-item>
            <p>Acute respiratory distress syndrome</p>
          </list-item>
          <list-item>
            <p>Suicide</p>
          </list-item>
          <list-item>
            <p>Traumatic brain disorders</p>
          </list-item>
          <list-item>
            <p>Toxic encephalopathy</p>
          </list-item>
          <list-item>
            <p>Primary aldosteronism</p>
          </list-item>
          <list-item>
            <p>Thyrotoxicosis</p>
          </list-item>
          <list-item>
            <p>Licorice with glycyrrhizin-induced pseudo-aldosteronism</p>
          </list-item>
          <list-item>
            <p>Neurovascular or neuromuscular disorders</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Neoplasms</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-154903.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Toluene toxicity has a proposed mortality rate of 15%.<xref ref-type="bibr" rid="article-154903.r9">[9]</xref> While extremely high, there are limited studies that record either morbidity or mortality. Acute exposure, if the patient is diagnosed and treated promptly, has minimal lasting complications. However,&#x000a0;signs of&#x000a0;altered mental status, severe metabolic acidosis, and concomitant&#x000a0;hypokalemia are associated with poor outcomes.&#x000a0;</p>
        <p>Complications from chronic use include tremors, peripheral neuropathy, cerebellar dysfunction, mood changes, chronic encephalopathy, gait disturbance, dementia, and spasticity.<xref ref-type="bibr" rid="article-154903.r38">[38]</xref>&#x000a0;There is conflicting evidence regarding&#x000a0;whether or not these complications are reversible.<xref ref-type="bibr" rid="article-154903.r49">[49]</xref><xref ref-type="bibr" rid="article-154903.r50">[50]</xref>&#x000a0;Significant improvement has been associated with abstinence, younger age, lower level of exposure, and initial symptoms at presentation.<xref ref-type="bibr" rid="article-154903.r51">[51]</xref>&#x000a0;Patients with encephalopathy have the worst rates of recovery.<xref ref-type="bibr" rid="article-154903.r38">[38]</xref></p>
      </sec>
      <sec id="article-154903.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Toluene toxicity can cause dangerous pulmonary, cardiac, and renal side effects, including acute respiratory distress syndrome, deadly cardiac arrhythmias, and renal failure. Complications regarding patients who are pregnant are not elucidated; however, reproductive and teratogenic risks have been described.<xref ref-type="bibr" rid="article-154903.r31">[31]</xref><xref ref-type="bibr" rid="article-154903.r52">[52]</xref></p>
      </sec>
      <sec id="article-154903.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Neither toluene toxicity nor inhalant dependence and misuse are discussed in the general population, which could be, in part, due to the lack of literature on the subject. A Cochrane review in 2010 assessed randomized-control trials and controlled clinical trials for the treatment of inhalant dependence and misuse but determined no studies met the inclusion criteria.<xref ref-type="bibr" rid="article-154903.r53">[53]</xref> A 2012 systematic review for volatile substance misuse failed to identify effective therapeutic interventions.<xref ref-type="bibr" rid="article-154903.r54">[54]</xref> One trial identified a significant decrease in inhalant misuse after&#x000a0;1 year of cognitive behavioral therapy intervention.<xref ref-type="bibr" rid="article-154903.r55">[55]</xref>&#x000a0;Additional studies must be completed that can strategize effective deterrence and provide information for patient education.</p>
      </sec>
      <sec id="article-154903.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Toxicities of any drug necessitate management by an interprofessional team of healthcare professionals. In addition to physicians, the role of pharmacists, social workers, case managers, and nurses cannot be overstated. Constant monitoring, education, and continued care after hospital discharge sometimes lead to improved patient outcomes and cessation of misuse behavior. All patients should be counseled on the recommended toluene exposure levels deemed safe, determined by their safety organization or safety manager. Finally, parents should be thoroughly educated on the variety of commercial products susceptible to toluene misuse, leading to toxicity.&#x000a0;</p>
      </sec>
      <sec id="article-154903.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=154903&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=154903">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/toluene-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=154903">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/154903/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=154903">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-154903.s15">
        <title>References</title>
        <ref id="article-154903.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fishbein</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>An overview of environmental and toxicological aspects of aromatic hydrocarbons. II. Toluene.</article-title>
            <source>Sci Total Environ</source>
            <year>1985</year>
            <month>Apr</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-88</page-range>
            <pub-id pub-id-type="pmid">3890176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruz</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Rivera-Garc&#x000ed;a</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Review of toluene action: clinical evidence, animal studies and molecular targets.</article-title>
            <source>J Drug Alcohol Res</source>
            <year>2014</year>
            <volume>3</volume>
            <pub-id pub-id-type="pmid">25360325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Beckley</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effects of the abused inhalant toluene on the mesolimbic dopamine system.</article-title>
            <source>J Drug Alcohol Res</source>
            <year>2014</year>
            <volume>3</volume>
            <pub-id pub-id-type="pmid">25360326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kondo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ichihara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kamijima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hisanaga</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakahara</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Toluene induces behavioral activation without affecting striatal dopamine metabolism in the rat: behavioral and microdialysis studies.</article-title>
            <source>Pharmacol Biochem Behav</source>
            <year>1995</year>
            <month>May</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-101</page-range>
            <pub-id pub-id-type="pmid">7617740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riegel</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride.</article-title>
            <source>Pharmacol Biochem Behav</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-402</page-range>
            <pub-id pub-id-type="pmid">10080229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Funada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makino</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of rewarding effect of toluene by the conditioned place preference procedure in mice.</article-title>
            <source>Brain Res Brain Res Protoc</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-54</page-range>
            <pub-id pub-id-type="pmid">12379437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Gerasimov</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Schiffer</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Gifford</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Concentration-dependent conditioned place preference to inhaled toluene vapors in rats.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2006</year>
            <month>Oct</month>
            <day>15</day>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-90</page-range>
            <pub-id pub-id-type="pmid">16675162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Wiley</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Balster</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The effects of abused inhalants on mouse behavior in an elevated plus-maze.</article-title>
            <source>Eur J Pharmacol</source>
            <year>1996</year>
            <month>Sep</month>
            <day>26</day>
            <volume>312</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-6</page-range>
            <pub-id pub-id-type="pmid">8894586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camara-Lemarroy</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Guti&#x000e9;rrez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Monreal-Robles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Gonz&#x000e1;lez</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Acute toluene intoxication--clinical presentation, management and prognosis: a prospective observational study.</article-title>
            <source>BMC Emerg Med</source>
            <year>2015</year>
            <month>Aug</month>
            <day>18</day>
            <volume>15</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">26282250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winchester</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Madjar</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Solvent effects on workers in the paint, adhesive and printing industries.</article-title>
            <source>Ann Occup Hyg</source>
            <year>1986</year>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-17</page-range>
            <pub-id pub-id-type="pmid">3777750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>WOLF</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>ROWE</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>MCCOLLISTER</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>HOLLINGSWORTH</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>OYEN</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Toxicological studies of certain alkylated benzenes and benzene; experiments on laboratory animals.</article-title>
            <source>AMA Arch Ind Health</source>
            <year>1956</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>387</fpage>
            <page-range>387-98</page-range>
            <pub-id pub-id-type="pmid">13361560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rooseboom</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kocabas</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>North</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Radcliffe</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Recommendation for an occupational exposure limit for toluene.</article-title>
            <source>Regul Toxicol Pharmacol</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>141</volume>
            <fpage>105387</fpage>
            <pub-id pub-id-type="pmid">37169161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Balster</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Deaths associated with inhalant abuse in Virginia from 1987 to 1996.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>1999</year>
            <month>Feb</month>
            <day>01</day>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>239</fpage>
            <page-range>239-45</page-range>
            <pub-id pub-id-type="pmid">10080050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bass</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Sudden sniffing death.</article-title>
            <source>JAMA</source>
            <year>1970</year>
            <month>Jun</month>
            <day>22</day>
            <volume>212</volume>
            <issue>12</issue>
            <fpage>2075</fpage>
            <page-range>2075-9</page-range>
            <pub-id pub-id-type="pmid">5467774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome.</article-title>
            <source>Subst Use Misuse</source>
            <year>2011</year>
            <volume>46 Suppl 1</volume>
            <fpage>68</fpage>
            <page-range>68-72</page-range>
            <pub-id pub-id-type="pmid">21609149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hobara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gotoh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Segawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kunitsugu</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Estimation of the lethal toluene concentration from the accidental death of painting workers.</article-title>
            <source>Ind Health</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>228</fpage>
            <page-range>228-31</page-range>
            <pub-id pub-id-type="pmid">10812847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckley</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Volatile solvents as drugs of abuse: focus on the cortico-mesolimbic circuitry.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>13</issue>
            <fpage>2555</fpage>
            <page-range>2555-67</page-range>
            <pub-id pub-id-type="pmid">23954847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cairney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maruff</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Currie</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The neurobehavioural consequences of petrol (gasoline) sniffing.</article-title>
            <source>Neurosci Biobehav Rev</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-9</page-range>
            <pub-id pub-id-type="pmid">11835986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hynes-Dowell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mateu-Gelabert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Delva</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Volatile substance misuse among high school students in South America.</article-title>
            <source>Subst Use Misuse</source>
            <year>2011</year>
            <volume>46 Suppl 1</volume>
            <issue>0 1</issue>
            <fpage>27</fpage>
            <page-range>27-34</page-range>
            <pub-id pub-id-type="pmid">21609142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Toluene: correlation between occupational exposure limits and biological exposure indices.</article-title>
            <source>Rev Bras Med Trab</source>
            <year>2022</year>
            <season>Oct-Dec</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>633</fpage>
            <page-range>633-641</page-range>
            <pub-id pub-id-type="pmid">37101451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f6;f</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>N&#x000e4;slund</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wall&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hjelm</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Relationship between uptake and elimination of toluene and debrisoquin hydroxylation polymorphism.</article-title>
            <source>Clin Pharmacol Ther</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>412</fpage>
            <page-range>412-7</page-range>
            <pub-id pub-id-type="pmid">2311341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cosnier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brochard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burgart</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cossec</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Mercapturic acids derived from toluene in rat urine samples: identification and measurement by gas chromatography-tandem mass spectrometry.</article-title>
            <source>Anal Bioanal Chem</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>404</volume>
            <issue>6-7</issue>
            <fpage>1907</fpage>
            <page-range>1907-17</page-range>
            <pub-id pub-id-type="pmid">22829455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bale</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Smothers</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene.</article-title>
            <source>Br J Pharmacol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-83</page-range>
            <pub-id pub-id-type="pmid">12237258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruz</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mirshahi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Balster</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>286</volume>
            <issue>1</issue>
            <fpage>334</fpage>
            <page-range>334-40</page-range>
            <pub-id pub-id-type="pmid">9655877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckley</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>1531</fpage>
            <page-range>1531-42</page-range>
            <pub-id pub-id-type="pmid">21430649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckstead</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Eger</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mihic</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse.</article-title>
            <source>Mol Pharmacol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>1199</fpage>
            <page-range>1199-205</page-range>
            <pub-id pub-id-type="pmid">10825391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopreato</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Phelan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borghese</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Beckstead</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mihic</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Inhaled drugs of abuse enhance serotonin-3 receptor function.</article-title>
            <source>Drug Alcohol Depend</source>
            <year>2003</year>
            <month>May</month>
            <day>01</day>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-5</page-range>
            <pub-id pub-id-type="pmid">12681521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yakes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Christiani</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Occupational skin disease in newspaper pressroom workers.</article-title>
            <source>J Occup Med</source>
            <year>1991</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>711</fpage>
            <page-range>711-7</page-range>
            <pub-id pub-id-type="pmid">1830898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansbrough</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Zapata-Sirvent</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dominic</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boswick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>XW</given-names>
              </name>
            </person-group>
            <article-title>Hydrocarbon contact injuries.</article-title>
            <source>J Trauma</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>250</fpage>
            <page-range>250-2</page-range>
            <pub-id pub-id-type="pmid">3981678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kornfeld</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Kleinschmidt-DeMasters</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nolte</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Solvent vapor abuse leukoencephalopathy. Comparison to adrenoleukodystrophy.</article-title>
            <source>J Neuropathol Exp Neurol</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>389</fpage>
            <page-range>389-98</page-range>
            <pub-id pub-id-type="pmid">8021713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannigan</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Reproductive toxicology and teratology of abused toluene.</article-title>
            <source>Syst Biol Reprod Med</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-200</page-range>
            <pub-id pub-id-type="pmid">20377315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Svenson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Acute exposure to abuse-like concentrations of toluene induces inflammation in mouse lungs and brain.</article-title>
            <source>J Appl Toxicol</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>42</volume>
            <issue>7</issue>
            <fpage>1168</fpage>
            <page-range>1168-1177</page-range>
            <pub-id pub-id-type="pmid">34993988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baydas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reiter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Nedzvetskii</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Ya&#x0015f;ar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozveren</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Canatan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Melatonin protects the central nervous system of rats against toluene-containing thinner intoxication by reducing reactive gliosis.</article-title>
            <source>Toxicol Lett</source>
            <year>2003</year>
            <month>Feb</month>
            <day>03</day>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-74</page-range>
            <pub-id pub-id-type="pmid">12523959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abouee-Mehrizi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rasoulzadeh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mesgari-Abbasi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mehdipour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ebrahimi-Kalan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nephrotoxic effects caused by co-exposure to noise and toluene in New Zealand white rabbits: A biochemical and histopathological study.</article-title>
            <source>Life Sci</source>
            <year>2020</year>
            <month>Oct</month>
            <day>15</day>
            <volume>259</volume>
            <fpage>118254</fpage>
            <pub-id pub-id-type="pmid">32800833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurtzman</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Otsuka</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Wahl</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Inhalant abuse by adolescents.</article-title>
            <source>J Adolesc Health</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-80</page-range>
            <pub-id pub-id-type="pmid">11226839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Storck</surname>
                <given-names>M</given-names>
              </name>
              <collab>American Academy of Pediatrics Committee on Substance Abuse</collab>
              <collab>American Academy of Pediatrics Committee on Native American Child Health</collab>
            </person-group>
            <article-title>Inhalant abuse.</article-title>
            <source>Pediatrics</source>
            <year>2007</year>
            <month>May</month>
            <volume>119</volume>
            <issue>5</issue>
            <fpage>1009</fpage>
            <page-range>1009-17</page-range>
            <pub-id pub-id-type="pmid">17473104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howard</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Garland</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Perron</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Vaughn</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Inhalant use and inhalant use disorders in the United States.</article-title>
            <source>Addict Sci Clin Pract</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-31</page-range>
            <pub-id pub-id-type="pmid">22003419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tormoehlen</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Tekulve</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Na&#x000f1;agas</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Hydrocarbon toxicity: A review.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>479</fpage>
            <page-range>479-89</page-range>
            <pub-id pub-id-type="pmid">24911841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shepherd</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of sudden death associated with volatile substance abuse.</article-title>
            <source>Hum Toxicol</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-91</page-range>
            <pub-id pub-id-type="pmid">2777268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olgar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oktem</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dindar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kilbas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turkoglu</surname>
                <given-names>UD</given-names>
              </name>
              <name>
                <surname>Cetin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Altuntas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ertugrul</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Omeroglu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aydogan</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Volatile solvent abuse caused glomerulopathy and tubulopathy in street children.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>477</fpage>
            <page-range>477-83</page-range>
            <pub-id pub-id-type="pmid">18784200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thiesen</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Noto</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Laboratory diagnosis of toluene-based inhalants abuse.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2007</year>
            <season>Jun-Aug</season>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>557</fpage>
            <page-range>557-62</page-range>
            <pub-id pub-id-type="pmid">17503266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Streicher</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Gabow</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Kono</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaehny</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>Syndromes of toluene sniffing in adults.</article-title>
            <source>Ann Intern Med</source>
            <year>1981</year>
            <month>Jun</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>758</fpage>
            <page-range>758-62</page-range>
            <pub-id pub-id-type="pmid">7235417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Renal disease associated with toluene inhalation.</article-title>
            <source>J Toxicol Clin Toxicol</source>
            <year>1986</year>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-23</page-range>
            <pub-id pub-id-type="pmid">3014162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garland</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>MO</given-names>
              </name>
            </person-group>
            <article-title>Phenomenology of adolescent inhalant intoxication.</article-title>
            <source>Exp Clin Psychopharmacol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>498</fpage>
            <page-range>498-509</page-range>
            <pub-id pub-id-type="pmid">21186924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kopec</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Brent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Banner</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ruha</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Leikin</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Management of cardiac dysrhythmias following hydrocarbon abuse: clinical toxicology teaching case from NACCT acute and intensive care symposium.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-5</page-range>
            <pub-id pub-id-type="pmid">24476044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colombier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pr&#x000ea;tre</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Iafrate</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niclauss</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Double-stage venous cannulation combined with Avalon&#x000ae; cannula for potential prolongation of respiratory ECMO in end-stage pulmonary disease.</article-title>
            <source>Perfusion</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>593</fpage>
            <page-range>593-7</page-range>
            <pub-id pub-id-type="pmid">27015915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dice</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kilpatrick</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary toxicity following gastrointestinal ingestion of kerosene.</article-title>
            <source>Ann Emerg Med</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>138</fpage>
            <page-range>138-42</page-range>
            <pub-id pub-id-type="pmid">7065488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khanna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Devgan</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hydrocarbon pneumonitis following diesel siphonage.</article-title>
            <source>Indian J Chest Dis Allied Sci</source>
            <year>2004</year>
            <season>Apr-Jun</season>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-32</page-range>
            <pub-id pub-id-type="pmid">15072330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lubman</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Y&#x000fc;cel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Inhalant abuse among adolescents: neurobiological considerations.</article-title>
            <source>Br J Pharmacol</source>
            <year>2008</year>
            <month>May</month>
            <volume>154</volume>
            <issue>2</issue>
            <fpage>316</fpage>
            <page-range>316-26</page-range>
            <pub-id pub-id-type="pmid">18332858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dingwall</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Cairney</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Recovery from central nervous system changes following volatile substance misuse.</article-title>
            <source>Subst Use Misuse</source>
            <year>2011</year>
            <volume>46 Suppl 1</volume>
            <fpage>73</fpage>
            <page-range>73-83</page-range>
            <pub-id pub-id-type="pmid">21609150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Valen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wekking</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van der Laan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sprangers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The course of chronic solvent induced encephalopathy: a systematic review.</article-title>
            <source>Neurotoxicology</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>1172</fpage>
            <page-range>1172-86</page-range>
            <pub-id pub-id-type="pmid">19538991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamid</surname>
                <given-names>OIA</given-names>
              </name>
              <name>
                <surname>Domouky</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>El-Fakharany</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Molecular evidence of the amelioration of toluene induced encephalopathy by human breast milk mesenchymal stem cells.</article-title>
            <source>Sci Rep</source>
            <year>2022</year>
            <month>Jun</month>
            <day>02</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>9194</fpage>
            <pub-id pub-id-type="pmid">35654991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konghom</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verachai</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Srisurapanont</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suwanmajo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ranuwattananon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kimsongneun</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Uttawichai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Treatment for inhalant dependence and abuse.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2010</year>
            <month>Dec</month>
            <day>08</day>
            <issue>12</issue>
            <fpage>CD007537</fpage>
            <pub-id pub-id-type="pmid">21154379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacLean</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NK</given-names>
              </name>
            </person-group>
            <article-title>Psychosocial therapeutic interventions for volatile substance use: a systematic review.</article-title>
            <source>Addiction</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>278</fpage>
            <page-range>278-88</page-range>
            <pub-id pub-id-type="pmid">22248138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-154903.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;gel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coskun</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cognitive behavioral therapy-based brief intervention for volatile substance misusers during adolescence: a follow-up study.</article-title>
            <source>Subst Use Misuse</source>
            <year>2011</year>
            <volume>46 Suppl 1</volume>
            <fpage>128</fpage>
            <page-range>128-33</page-range>
            <pub-id pub-id-type="pmid">21609157</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
